Page last updated: 2024-11-05

ticlopidine and Adenocarcinoma Of Kidney

ticlopidine has been researched along with Adenocarcinoma Of Kidney in 1 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Research Excerpts

ExcerptRelevanceReference
"We describe a patient with terminal renal cell carcinoma who developed late iliac artery stent thrombosis despite dual chronic antiplatelet therapy with aspirin and clopidogrel."1.36Late common iliac artery stent thrombosis in a patient with terminal malignancy. ( Akgün, T; Can, MM; Karabay, CY; Kaymaz, C; Ozveren, O; Serebruany, V; Tanboğa, IH; Tokgöz, HC; Türkyilmaz, E, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Can, MM1
Tanboğa, IH1
Ozveren, O1
Karabay, CY1
Akgün, T1
Türkyilmaz, E1
Tokgöz, HC1
Kaymaz, C1
Serebruany, V1

Other Studies

1 other study available for ticlopidine and Adenocarcinoma Of Kidney

ArticleYear
Late common iliac artery stent thrombosis in a patient with terminal malignancy.
    Cardiology, 2010, Volume: 115, Issue:4

    Topics: Aged; Angiography; Aspirin; Atherosclerosis; Carcinoma, Renal Cell; Clopidogrel; Humans; Iliac Arter

2010